D
Lucid Diagnostics Inc. LUCD
$1.26 $0.086.78% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -18.44% -31.46% 13.55% 21.05% 18.01%
Total Depreciation and Amortization -55.65% -62.86% -53.30% -36.66% -19.12%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 85.96% 190.26% -60.15% -69.89% -53.94%
Change in Net Operating Assets 74.64% -600.57% -178.08% -146.69% -132.72%
Cash from Operations -0.48% -14.84% -34.50% -63.30% -73.77%
Capital Expenditure -66.81% -46.06% -33.94% 14.86% 59.35%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -221.68% -191.29% -192.31% -125.70% 85.48%
Total Debt Issued -- -- 116.15% -100.00% -100.00%
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 4,904.91% 2,300.63% -45.99% -46.05% -74.55%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -100.00% -49.78% 59.99% 155.40% 155.40%
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 41.10% 89.79% 63.77% 44.10% 35.71%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 181.08% 103.18% 196.76% -231.52% -6,918.35%